🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 20 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/09/2011 | 9,38 | 9,59 | 9,30 | 9,53 | +1,87% | 3,19% | 172.162 |
| 12/09/2011 | 9,19 | 9,58 | 9,19 | 9,35 | -1,19% | 4,28% | 146.354 |
| 09/09/2011 | 9,56 | 9,67 | 9,31 | 9,46 | -1,69% | 3,72% | 275.556 |
| 08/09/2011 | 10,07 | 10,13 | 9,61 | 9,63 | -3,26% | 5,20% | 272.510 |
| 07/09/2011 | 8,91 | 9,95 | 8,91 | 9,95 | +13,69% | 11,69% | 400.590 |
| 06/09/2011 | 8,63 | 8,80 | 8,42 | 8,75 | -1,68% | 4,34% | 405.399 |
| 02/09/2011 | 9,21 | 9,41 | 8,84 | 8,90 | -4,87% | 6,17% | 311.623 |
| 01/09/2011 | 9,49 | 9,65 | 9,31 | 9,36 | -1,51% | 3,55% | 202.619 |
| 31/08/2011 | 9,64 | 9,91 | 9,26 | 9,50 | -0,52% | 6,67% | 325.890 |
| 30/08/2011 | 9,23 | 9,64 | 9,14 | 9,55 | +2,34% | 5,41% | 310.020 |
| 29/08/2011 | 7,87 | 9,38 | 7,86 | 9,33 | +19,97% | 19,26% | 714.778 |
| 26/08/2011 | 7,82 | 7,91 | 7,64 | 7,78 | +0,81% | 3,51% | 348.332 |
| 25/08/2011 | 8,15 | 8,15 | 7,72 | 7,72 | -4,70% | 5,36% | 280.685 |
| 24/08/2011 | 7,65 | 8,13 | 7,30 | 8,10 | +6,22% | 10,93% | 493.083 |
| 23/08/2011 | 7,58 | 7,65 | 7,43 | 7,62 | +1,24% | 2,88% | 366.766 |
| 22/08/2011 | 7,64 | 7,67 | 7,36 | 7,53 | +0,92% | 4,17% | 201.497 |
| 19/08/2011 | 7,34 | 7,62 | 7,22 | 7,46 | -0,33% | 5,44% | 332.943 |
| 18/08/2011 | 7,51 | 7,54 | 7,39 | 7,49 | -3,07% | 2,08% | 238.847 |
| 17/08/2011 | 7,85 | 7,85 | 7,50 | 7,72 | -0,64% | 4,45% | 189.154 |
| 16/08/2011 | 7,57 | 7,91 | 7,34 | 7,77 | +1,55% | 7,59% | 215.924 |
| 15/08/2011 | 7,77 | 7,80 | 7,39 | 7,65 | +1,15% | 5,30% | 194.284 |
| 12/08/2011 | 7,29 | 7,62 | 7,15 | 7,57 | +4,66% | 6,50% | 201.337 |
| 11/08/2011 | 6,96 | 7,34 | 6,87 | 7,23 | +3,85% | 6,82% | 325.249 |
| 10/08/2011 | 6,68 | 7,04 | 6,44 | 6,96 | +2,48% | 8,96% | 938.396 |
| 09/08/2011 | 7,11 | 7,11 | 6,63 | 6,79 | -2,94% | 6,76% | 885.177 |
| 08/08/2011 | 6,86 | 7,11 | 6,34 | 7,00 | -3,69% | 11,18% | 649.375 |
| 05/08/2011 | 7,62 | 7,79 | 7,26 | 7,27 | -3,64% | 6,96% | 243.335 |
| 04/08/2011 | 8,06 | 8,48 | 7,54 | 7,54 | -7,64% | 11,69% | 252.953 |
| 03/08/2011 | 8,22 | 8,22 | 7,92 | 8,17 | -0,31% | 3,64% | 256.640 |
| 02/08/2011 | 8,40 | 8,52 | 8,17 | 8,19 | -2,96% | 4,16% | 251.831 |